EGFR and lung adenocarcinoma: A previous comparative analysis between advanced- and early stage lung adenocarcinomas also confirmed that EGFR mutation was not correlated with gender, but the proportion of smokers in patients with early stage lung adenocarcinoma was higher than that in the advanced [30].